Glenmark Life Sciences Balance Sheet Health
Financial Health criteria checks 6/6
Glenmark Life Sciences has a total shareholder equity of ₹23.9B and total debt of ₹182.8M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are ₹29.5B and ₹5.6B respectively. Glenmark Life Sciences's EBIT is ₹6.9B making its interest coverage ratio -47.7. It has cash and short-term investments of ₹4.4B.
Key information
0.8%
Debt to equity ratio
₹182.84m
Debt
Interest coverage ratio | -47.7x |
Cash | ₹4.43b |
Equity | ₹23.92b |
Total liabilities | ₹5.61b |
Total assets | ₹29.53b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 543322's short term assets (₹20.8B) exceed its short term liabilities (₹5.0B).
Long Term Liabilities: 543322's short term assets (₹20.8B) exceed its long term liabilities (₹622.4M).
Debt to Equity History and Analysis
Debt Level: 543322 has more cash than its total debt.
Reducing Debt: 543322's debt to equity ratio has reduced from 1326.2% to 0.8% over the past 5 years.
Debt Coverage: 543322's debt is well covered by operating cash flow (2484.6%).
Interest Coverage: 543322 earns more interest than it pays, so coverage of interest payments is not a concern.